Related references
Note: Only part of the references are listed.Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage
Umesh Sharma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction
Marianna Papaspyridonos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices
Hendrik Milting et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2008)
Regulation of alternative macrophage activation by galectin-3
Alison C. MacKinnon et al.
JOURNAL OF IMMUNOLOGY (2008)
Decreased endogenous levels of Ac-SDKP promote organ fibrosis
Maria A. Cavasin et al.
HYPERTENSION (2007)
The role of TGF-β signaling in myocardial infarction and cardiac remodeling
Marcin Bujak et al.
CARDIOVASCULAR RESEARCH (2007)
Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice
Machteld J. van Amerongen et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Integrins, vascular remodeling, and hypertension
Egidius H. J. Heerkens et al.
HYPERTENSION (2007)
Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure
Roland R. van Kimmenade et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Towards functional glycomics by localization of binding sites for tissue lectins:: lectin histochemical reactivity for galectins during diethylstilbestrol-induced kidney tumorigenesis in male Syrian hamster
Sven Saussez et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2006)
Targeting integrins: Insights into structure and activity of cyclic RGD pentapeptide mimics containing azabicycloalkane amino acids
L Belvisi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
A guide to signaling pathways connecting protein-glycan interaction with the emerging versatile effector functionality of mammalian lectins
Antonio Villalobo et al.
TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY (2006)
Angiotensin-converting enzyme inhibitors - A new mechanism of action
HM Peng et al.
CIRCULATION (2005)
Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling
YM Zhan et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
A systematic review of large scale and heterogeneous gene array data in heart failure
UC Sharma et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Reduction of cardiac fibrosis decreases systolic performance without affecting diastolic function in hypertensive rats
OH Cingolani et al.
HYPERTENSION (2004)
Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes
N Ahmad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Antifibrotic effect of Ac-SDKP and angiotensin-converting enzyme inhibition in hypertension
S Rasoul et al.
JOURNAL OF HYPERTENSION (2004)
Ac-SDKP reverses inflammation and fibrosis in rats with heart failure after myocardial infarction
F Yang et al.
HYPERTENSION (2004)
Increased myocardial collagen content in transgenic rats overexpressing cardiac angiotensin-converting enzyme is related to enhanced breakdown of N-acetyl-Ser-Asp-Lys-Pro and increased phosphorylation of Smad2/3
S Pokharel et al.
CIRCULATION (2004)
Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction
UC Sharma et al.
CIRCULATION (2004)
Determination of modulation of ligand properties of synthetic complex-type biantennary N-glycans by introduction of bisecting GlcNAc in silico, in vitro and in vivo
S Andre et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
N-acetyl-seryl-aspartyl-lysyl-proline stimulates angiogenesis in vitro and in vivo
DH Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
A role for cardiac mast cells in the pathogenesis of hypertensive heart disease
N Shiota et al.
JOURNAL OF HYPERTENSION (2003)
The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo
JM Liu et al.
BLOOD (2003)
Ac-SDKP reverses cardiac fibrosis in rats with renovascular hypertension
HM Peng et al.
HYPERTENSION (2003)
Inflammatory mediators and the failing heart - Past, present, and the foreseeable future
DL Mann
CIRCULATION RESEARCH (2002)
N-Acetyl-Ser-Asp-Lys-Pro inhibits phosphorylation of Smad2 in cardiac fibroblasts
S Pokharel et al.
HYPERTENSION (2002)
Doppler echocardiographic estimation of left ventricular end-diastolic pressure after MI in rats
F Prunier et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Pharmacokinetic advantage of intrapericardially applied substances in the rat
JJR Hermans et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
The inflammatory response in myocardial infarction
NG Frangogiannis et al.
CARDIOVASCULAR RESEARCH (2002)
Long-term effect of N-acetyl-seryl-aspartyl-lysyl-proline on left ventricular collagen deposition in rats with 2-kidney, 1-clip hypertension
NE Rhaleb et al.
CIRCULATION (2001)
Effect of N-acetyl-seryl-aspartyl-lysyl-proline on DNA and collagen synthesis in rat cardiac fibroblasts
NE Rhaleb et al.
HYPERTENSION (2001)
Antifibrotic effects of N-acetyl-seryl-aspartyl-lysyl-proline on the heart and kidney in aldosterone-salt hypertensive rats
HM Peng et al.
HYPERTENSION (2001)